Fig. 3 | Scientific Reports

Fig. 3

From: Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients

Fig. 3The alternative text for this image may have been generated using AI.

Intraoperative data. Comparison of (A) peripheral and (B) portal cfDNA (copies/mL, mean, SD) and ctDNA (copies/mL, mean, SD) levels before and after tissue mobilization. (C) KRAS mutation detection in tumor specimen (“Tumor”) and in peripheral and/or portal vein, before and/or after tissue mobilization during surgery (“Peroperative ctDNA”). Recurrence-free survival (D) and Overall survival (E) according to evolution of ctDNA after mobilization comparing to before tissue mobilization. **** p < 0.0001, ** p < 0.01, * p < 0.05. ctDNA: Circulating tumor DNA, cfDNA: Circulating-Free DNA, NS: not significant, SD: Standard deviation.

Back to article page